These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 1893725

  • 1. Subcutaneous recombinant human erythropoietin treatment of children undergoing peritoneal dialysis.
    Fine RN.
    Contrib Nephrol; 1991; 89():186-9. PubMed ID: 1893725
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy of once- versus thrice-weekly subcutaneous recombinant human erythropoietin in children receiving continuous cycling peritoneal dialysis.
    Ongkingco JR, Ruley EJ, Turner ME, Fragale MR.
    Am J Nephrol; 1994; 14(1):14-8. PubMed ID: 8017476
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Self-administered daily subcutaneous recombinant human erythropoietin: an open randomised dose-finding study in ESRD patients receiving peritoneal dialysis.
    Slingeneyer A, Faller B, Laroche B, Ehmer B, Mion C.
    Contrib Nephrol; 1991; 88():159-68. PubMed ID: 2040178
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Erythropoietin and peritoneal dialysis: the efficacy of intraperitoneal dosing.
    Nissenson AR.
    Perit Dial Int; 1992; 12(4):350-2. PubMed ID: 1420491
    [No Abstract] [Full Text] [Related]

  • 10. [Human recombinant erythropoietin in treatment of uremic anemia in children with continual ambulatory peritoneal dialysis].
    Litwin M, Boguszewska-Baczkowska A, Jelonek A.
    Pol Tyg Lek; 1992; 49(6-7):135-6. PubMed ID: 8090665
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. One year's experience with recombinant erythropoietin in children undergoing continuous ambulatory or cycling peritoneal dialysis.
    Offner G, Hoyer PF, Latta K, Winkler L, Brodehl J, Scigalla P.
    Pediatr Nephrol; 1990 Sep; 4(5):498-500. PubMed ID: 2242315
    [Abstract] [Full Text] [Related]

  • 16. Effect of erythropoietin in continuous ambulatory peritoneal dialysis patients: comparison between intravenous and intraperitoneal administration.
    Nasu T, Mitui H, Shinohara Y, Hayashida S, Ohtuka H.
    Perit Dial Int; 1992 Sep; 12(4):373-7. PubMed ID: 1420496
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Recombinant human erythropoietin and peritoneal dialysis.
    Digenis GE, Yatzidis H.
    Int J Artif Organs; 1990 Jun; 13(6):344-6. PubMed ID: 2199378
    [No Abstract] [Full Text] [Related]

  • 20. Subcutaneous versus intravenous recombinant human erythropoietin administration in hemodialysis patients.
    Boran M, Dalva I, Yazicioğlu A, Cetin S.
    Nephron; 1993 Jun; 63(1):113-4. PubMed ID: 8446239
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.